Modalis Therapeutics Corporation (JP:4883)
:4883
Japanese Market

Modalis Therapeutics Corporation (4883) Income Statement

Compare
1 Followers

Modalis Therapeutics Corporation Income Statement

Last quarter (Q4 2024), Modalis Therapeutics Corporation's total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q4, Modalis Therapeutics Corporation's net income was ¥-257.66M. See Modalis Therapeutics Corporation’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 0.00¥ 0.00¥ 40.50M¥ 1.10M¥ 342.00M
Gross Profit
¥ 0.00¥ -731.00K¥ -83.17M¥ 1.10M¥ 342.00M
Operating Expenses
¥ 1.34B¥ 2.37B¥ 2.10B¥ 1.24B¥ 740.35M
Depreciation and Amortization
¥ 731.00K¥ 731.00K¥ 123.67M¥ 77.87M¥ 57.59M
EBITDA
¥ -2.15B¥ -2.37B¥ -2.58B¥ -667.55M¥ -381.96M
Operating Income
¥ -1.34B¥ -2.37B¥ -2.06B¥ -1.24B¥ -398.35M
Other Income/Expenses
¥ 20.72M¥ -19.94M¥ -643.84M¥ 494.03M¥ -41.20M
Pretax Income
¥ -1.32B¥ -2.39B¥ -2.71B¥ -745.42M¥ -439.55M
Net Income
¥ -1.32B¥ -2.39B¥ -2.70B¥ -738.96M¥ -448.41M
Per Share Metrics
Basic EPS
¥ -28.57¥ -77.24¥ -92.85¥ -25.70¥ -17.02
Diluted EPS
¥ -28.57¥ -77.24¥ -92.85¥ -25.70¥ -17.02
Weighted Average Shares Outstanding
46.13M 30.97M 29.11M 28.75M 26.35M
Weighted Average Shares Outstanding (Diluted)
46.13M 30.97M 29.11M 28.75M 26.35M
Currency in JPY

Modalis Therapeutics Corporation Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis